2023 Form 5500 filing — Igc Pharma, Inc. 401k Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241017164430NAL0018614435001) for Igc Pharma, Inc. 401k Plan, reported by Igc Pharma, Inc. under EIN 20-2760393 and plan number 001. It reports 38 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$1.8MReported net assets$1,785,089
Participants38
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
EFAST2 acknowledgement
20241017164430NAL0018614435001
Plan sponsor
Igc Pharma, Inc.
EIN
20-2760393
Plan number
001
Location
Potomac, MD
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule I · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$1.8M total assets
Net assets$1.8MLiabilities$0
Money in vs. money out
Total income / additions$489K
Total expenses$94.2K
Benefits paid / distributions$92.5K
Contributions
Employer$99K
Participant$158K
Full reported line items
Total assets (EOY)
$1,785,089
Total liabilities (EOY)
$0
Net assets (EOY)
$1,785,089
Employer contributions
$99,041
Participant contributions
$157,956
Total income / additions
$488,993
Benefits paid
$92,541
Administrative expenses
$1,688
Total expenses
$94,229
Net increase / (decrease)
$394,764

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20241017164430NAL0018614435001 cover?
It is the 2023 Form 5500 filing for Igc Pharma, Inc. 401k Plan, reported by Igc Pharma, Inc. (EIN 20-2760393).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule I (small plan financials).

Related Form 5500 pages